Business description – Dr Lalchandani Labs is formed to set up, engage, collaborate, acquire, purchase, maintain, open collection centres, conduct, manage, administer, own, run laboratories for the purposes of carrying out pathological investigations of various branches of Bio-Chemistry, Hematology, Histopathology, Microbiology, Electrophoresis, , Virology, Cytology, other pathological Investigations and Immunoassay, Immuno-Histochemistry, Molecular Pathology, Dna & Genetic Testing etc. The company is a provider of diagnostic and related healthcare tests and services in Delhi/NCR. Through its integrated network, it offers patients and healthcare providers a broad range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions. Its customers include individual patients, hospitals and other healthcare providers and corporate customers. The company is NABL Accredited Lab has established itself within Delhi/NCR with 5 (Five) Self-Sufficient Labs and multiple collection centers.
Promoters of Dr Lalchandani Labs – Mr Arjan Lal Chandani, Mr Mohit Lal Chandani and Mrs Anchal Gupta
| Dr Lalchandani Labs IPO details | |
| Subscription Dates | 25 – 27 April 2018 |
| IPO Price band | INR30 per share |
| Fresh issue | 1,400,000 shares (INR4.2 crore) |
| Offer for sale | Nil |
| Total IPO size | 1,400,000 shares (INR4.2 crore) |
| Minimum bid (lot size) | 4,000 shares |
| Face Value | INR10 per share |
| Retail Allocation | 50% |
| Listing On | BSE SME platform |
Use of funds
- To open second major processing center (2000 sq. ft. area) in Delhi/NCR – INR0.35 crore
- Repayment/pre-payment, in full or part, of certain borrowings – INR1.00 crore
- To purchase advanced machinery and equipment – INR0.50 crore
- To open new collection centers based on COCO model – INR0.27 crore
- To Develop E- Applications and E Programs and other I.T. support system – INR0.11 crore
- For Recruitment, Training and Placement of staff to expand operations and other operational expenses – INR0.62 crore
- For general corporate purposes – INR1.00 crore
- Issue Expenses – INR0.35 crore
| Dr Lalchandani Labs’ financial performance (in INR lakh) | ||||||
| FY2013 | FY2014 | FY2015 | FY2016 | FY2017 | ||
| Total revenue | 122.0 | 141.4 | 192.8 | 302.8 | 461.7 | |
| Total expenses | 120.0 | 137.3 | 160.9 | 270.6 | 390.9 | |
| Profit after tax | 1.9 | 4.1 | 31.9 | 32.2 | 70.7 | |
Dr Lalchandani Labs’ Contact Details
Dr Lalchandani Labs Limited
M-20 Basement
Greater Kailash-1
New Delhi 110 048
Phone: +91 011 4905 7058
Email: [email protected]
Website: www.lalchandanipathlab.com
Dr Lalchandani Labs IPO Subscription Details
| Day | Subscription (no. of times) |
| Day 1 | 0.22 |
| Day 2 | 1.46 |
| Day 3 | 4.44 |
Dr Lalchandani Labs Valuation (Latest FY)
Earnings Per Share (EPS): NA
Price/Earnings (P/E) ratio: NA
Return on Net Worth (RONW): NA
Net Asset Value (NAV): NA
Registrar of Dr Lalchandani Labs IPO
Cameo Corporate Services Limited
Subramanian Building, 1 Club House Road,
Chennai-600 002
Tamil Nadu, India
Phone: +91 44 2846 0390
Fax: +91 44 2846 0129
Email:Â [email protected]
Website:Â http://www.cameoindia.com
Dr Lalchandani Labs IPO Allotment Status
Dr Lalchandani Labs IPO allotment status is now available on Cameo Corporate Services’ website. Click on this link to get allotment status.
Listing performance of Dr Lalchandani Labs
IPO Opening Date: 25Â April 2018
IPO Closing Date: 27 April 2018
Listing Date: 9 May 2018
Listing Price on BSE SME: INR29.95 per share (down 0.16% from IPO price)
Closing Price on BSE SME: INR28.50 per share (down 5% from IPO price)
Sir what is your view ?